|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest bearing cash and temporary investments | ||||||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||||||
| Investment securities | ||||||||||||||||||||
| Equity and other, at fair value | ||||||||||||||||||||
| Available for sale, at fair value | ||||||||||||||||||||
| Held to maturity, at amortized cost | ||||||||||||||||||||
| Loans held for sale, at fair value | ||||||||||||||||||||
| Loans and leases (at fair value: $285,581 and $345,634) | ||||||||||||||||||||
| Allowance for credit losses on loans and leases | ||||||||||||||||||||
| Net loans and leases | ||||||||||||||||||||
| Restricted equity securities | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangible assets, net | ||||||||||||||||||||
| Residential mortgage servicing rights, at fair value | ||||||||||||||||||||
| Other Real Estate, Foreclosed Assets, and Repossessed Assets | ||||||||||||||||||||
| Bank owned life insurance | ||||||||||||||||||||
| Deferred tax asset, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||||||||||||||
| Deposits, Interest-bearing and Noninterest-bearing, Alternative | ||||||||||||||||||||
| Non-interest bearing | ||||||||||||||||||||
| Interest bearing | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Securities sold under agreements to repurchase | ||||||||||||||||||||
| Borrowings | ||||||||||||||||||||
| Junior subordinated debentures, at fair value | ||||||||||||||||||||
| Junior subordinated debentures, at amortized cost | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Deferred tax liability, net | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| SHAREHOLDERS' EQUITY | ||||||||||||||||||||
| Common Stock, Value, Issued | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive (loss) income | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Total liabilities and shareholders' equity | ||||||||||||||||||||
| Common stock, par value (in dollar per share) | ||||||||||||||||||||
| Common Stock, Shares Authorized | ||||||||||||||||||||
| Common Stock, Shares, Issued | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest bearing cash and temporary investments | ||||||||||||||||||||
| Total restricted cash | ||||||||||||||||||||
Loading...
